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Abstract
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Lipid membranes are suggested as the primary target of amyloid aggregates. We study aggregates
formed by a polyglutamine (polyQ) peptide, and their disruptive effect on lipid membranes. Using
solution atomic force microscopy (AFM), we observe polyQ oligomers coexisting with short
fibrils, which have a twisted morphology that likely corresponds to two intertwined oligomer
strings. Fourier transform infrared spectroscopy reveals that the content of β-sheet enriched
aggregates increases with incubation time. Using fluorescence microscopy, we find that exposure
to polyQ aggregates results in deflated morphology of giant unilamellar vesicles. PolyQ
aggregates induced membrane disruption is further substantiated by time-dependent calcein
leakage from the interior to the exterior of lipid vesicles. Detailed structural and mechanical
perturbations of lipid membranes are revealed by solution AFM. We find that membrane
disruption by polyQ aggregates proceeds by a two-step process, involving partial and full
disruption. In addition to height contrast, the resulting partially and fully disrupted bilayers have
distinct rigidity and adhesion force properties compared to the intact bilayer. Specifically, the
bilayer rigidity increases as the intact bilayer becomes partially and fully disrupted. Surprisingly,
the adhesion force first decreases and then increases during the disruption process. By resolving
individual fibrils deposited on bilayer surface, we show that both the length and the number of
fibrils can increase with incubation time. Our results highlight that membrane disruption could be
the molecular basis of polyQ aggregates induced cytotoxicity.
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To date, it is known that misfolding of expanded polyglutamine (polyQ) stretches is
responsible for at least ten types of neurodegenerative disorders in human [1]. Among them,
Huntington’s disease (HD) is the most notable one. HD is caused by an abnormal polyQ
stretch located near the N-terminus of the protein huntingtin (htt). It was found that the risk
of developing HD, as well as the severity of the disease, is greatly enhanced when the
number of glutamine repeats reaches a pathogenic threshold [2]. Numerous biochemical and
biophysical studies have indicated that polyQ stretches have the generic amyloidogenetic
propensity of forming protease resistant aggregates, a common theme shared by many
amyloid proteins and peptides, including amyloid-β in Alzheimer’s disease, α-synuclein in
Parkinson’s disease, islet amyloid polypeptide in type II diabetes mellitus, and prion protein
in Creutzfeldt-Jakob disease.
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One hallmark of HD is the formation of fibrillar inclusion bodies in intranuclear and
cytoplasmic spaces. Kinetic studies using model peptides have established that polyQ fibrils
are formed following classic nucleated polymerization mechanism [3, 4]. Additional studies
suggested that the nucleus size is dependent on polyQ repeat length [5]; flanking sequences
associated with htt can further alter polyQ aggregation behavior and kinetics [6, 7]. The
existence of polymorphic aggregates complicates structure-dysfunction relationship in
polyQ associated disorders, i.e., what is the molecular species responsible for cytotoxicity
along the pathogenic pathway [8]? Indeed, both mature fibrils [9-11] and elusive oligomers
[12-18] have been documented as the toxic determinant.
Studies comparing molecular bases of amyloidogenic diseases indicated that despite
sequence diversity, all amyloid oligomers share a common conformation that is ubiquitously
recognized by specifically designed antibodies [13]. Electrophysiological measurements
revealed that all soluble oligomers increased membrane ion conductivity, while fibrils had
no such effect. Based on these observations, a common mechanism of membrane targeting
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and permeabilization was conceptualized [19]. This view was reinforced by observations
that amyloid pathogenesis can be caused by aggregates localized either in the extracellular
or cytosolic space. In addition, cytotoxicity was conserved when cytosolic aggregates were
administered externally [13, 19]. In line with the membrane permeabilization mechanism,
many amyloidogogenic proteins and peptides were found to reorganize membrane structure,
such as α-synuclein [20], amyloid-β [21], islet amyloid polypeptide [22], and prion protein
fragment [23]. Membrane disruption by polyQ aggregates has also been observed. In
particular, both polyQ repeat length [24] and flanking sequence [25] were found to play a
role in modulating membrane integrity.
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Despite the accumulating knowledge, molecular basis of polyQ induced membrane
disruption remain poorly understood. For example, it is unclear what molecular species of
polyQ causes membrane depolarization. Large amorphous polyQ aggregates that do not
correspond well to either oligomeric or fibrillar structures were observed on bilayer surfaces
[24]. Are these amorphous aggregates causing lipid bilayer disruption, or are they just
loosely associated with bilayer surface due to electrostatic interactions? Similarly, large
aggregates of polyQ with better-defined morphologies have been observed on bilayer
surfaces [25]. The authors referred to these aggregates as “oligomers”. One intriguing fact is
that these “oligomers” are much larger compared to soluble oligomers observed on mica
surface. How are these “oligomers” generated? Are they responsible for lipid bilayer
permeabilization? AFM based studies have shown that polyQ aggregates enhance lipid
membrane roughness, a structural feature that might be related to lipid membrane
depolarization [24, 25]. However, it is unclear what species is causing membrane
roughening. Finally, the details of polyQ aggregates induced membrane disruption are
unknown. Are membranes permeabilized by amyloid pores [26] or by nonspecific
membrane disruption [19]? The molecular mechanism of membrane disruption is further
confounded by observations that membrane surface can alter amyloid aggregation [27, 28].
By suppressing aggregates’ mobility, lipid membranes can either catalyze amyloid
aggregation [29] or reverse the aggregated product [30].
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Here we use a simple lipid bilayer system to study the interplay between polyQ aggregates
and the underlying lipid matrix. We first use solution AFM to obtain structures of polyQ
aggregates generated by our modified preparation protocol. Our solution AFM measurement
shows that globular oligomers and short fibrils coexist on mica surface. The secondary
structure of polyQ as a function of incubation time is revealed by attenuated total reflection
Fourier transformation infrared (FTIR) spectroscopy. To qualitatively assess membrane
perturbation imparted by polyQ aggregates, we use fluorescence microscopy of ~30 μm
sized giant unilamellar vesicles (GUVs) and fluorescence spectroscopy of ~120 nm sized
unilamellar vesicles (ULVs). Membrane perturbation is confirmed by morphological
changes of GUVs and time-dependent calcein leakage from ULVs. Finally, we use solution
AFM to investigate polyQ induced structural and mechanical perturbation of mica supported
planar lipid bilayers. We find that membrane disruption is a two-step process involving
partial and full disruption. The resulting partially and fully disrupted bilayers have district
structural, mechanical, and adhesion force properties. Our solution AFM also shows
individual fibrils deposited on bilayer surfaces. Interestingly, we find that bilayer associated
fibrils can grow in length. Based on our high-resolution data, we speculate that polyQ
Biochim Biophys Acta. Author manuscript; available in PMC 2017 April 01.
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oligomers are the toxic species causing lipid bilayer disruption. Our experimental data
highlight that membrane disruption by polyQ aggregates can be the molecular basis of
polyQ induced cytotoxicity.

Materials and Methods
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and rhodamine-DPPE (1,2-dipalmitoylsn-glycero-3-phosphoethanolamine), in powder form, were purchased from Avanti Polar
Lipids (Alabaster, AL). All other reagents were purchased from Fisher Scientific
(Pittsburgh, PA).
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PolyQ35 peptide (KK-Q35-KK) was synthesized by solid phase synthesis method. To
enhance water solubility, the polyQ stretch was flanked by two lysine residues at the N- and
C-termini. The flanking residues likely modify aggregation kinetics [31], although the
resulting aggregates seem to be unchanged [32]. Synthesized peptide was purified by HPLC,
followed by lyophilization. Peptide molecular weight was confirmed by a mass spectrometer
(Bruker AutoFlex MALDI-TOF). PolyQ35 aggregates were prepared by dissolving peptide
powder (100 μM) in 10 mM HEPES at pH 7.4. The stock solution was kept at 4.0°C.
Aliquots incubated for different days were used for FTIR, fluorescence microscopy, and
solution AFM measurements. (All measurements were performed at room temperature). For
calcein leakage experiment, peptide aliquots were collected at different time points, snapfrozen in liquid nitrogen, and stored at −80°C. Ice-thawed aliquots were mixed with calceinencapsulated ULVs for calcein leakage assay.
Attenuated total refection FTIR
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Attenuated total reflection FTIR measurements at room temperature (23°C) were performed
using a Vertex 70 Bio ATRII spectrometer (Bruker, Billerica, MA). A fresh aliquot (30 μl)
of polyQ35 incubated for different days at 4°C was loaded into the silicon crystal sample
cell. For pelleted aggregates, an aliquot incubated for 7 days was centrifuged at 13000 rpm
for 10 min. The pellet was washed for 3 times before bringing to the initial volume. Infrared
absorption spectra were collected at wavenumbers from 400 to 4000 cm−1 with a resolution
of 2 cm−1 (averaged over 1500 scans). The time takes for one dataset collection is ~40 min.
Spectra were corrected for background absorption arising from the 10 mM HEPES buffer.
Fluorescence microscopy

Author Manuscript

DOPC+0.2mol% rhodamine-DPPE were prepared by mixing appropriate amount of lipid
stock solutions. After depositing onto ITO coated glass slides, lipid dry films were
vacuumed for > 2 h to remove organic solvents. A GUV production chamber filled with 100
mM sucrose and 10 mM HEPES (pH 7.4) was formed by sealing lipid dry films with a
Viton O-ring. The assemblage was heated to 60°C using a Digi-Sense temperature
controller. GUVs were generated by lipid swelling under an AC field of 10 Hz and 2.0 Volt
(duration of 2 h). GUV solution was transferred to 3 mL buffer containing 100 mM glucose
and 10 mM HEPES (pH 7.4). After settling for > 1 h, GUV aliquot from the bottom was
transferred onto a coverslip and examined by fluorescence microscopy using a Nikon
Eclipse-U microscope and an Andor iXon Ultra 897 EM-CCD. To retard liquid evaporation,
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the cover slip was housed in a homemade hollow chamber sealed by copper plates and
thermal insulation foam. To study the effect of polyQ35 aggregates, an equal volume of
peptide solution (after adjusting glucose concentration to 100 mM) was mixed with a GUV
aliquot (final peptide concentration was 15 μM). Immediately after mixing, time-lapse or
single-shot fluorescence micrographs were collected. Control experiments were performed
by mixing buffer-only solution with the GUV aliquot.
Calcein leakage assay
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DOPC dry film was hydrated by 1 mL 10 mM HEPES buffer (pH 7.4) containing 20 mM
NaCl and 30 mM calcein. Freeze-thaw cycles (6 times total) between −80 and 50°C were
carried out to ensure uniform distribution of calcein. The resultant lipid suspension was
extruded using an Avanti mini-extruder outfitted with a 100-nm-diameter pore filter to
produce ULVs. An ÄKTA pure FPLC (GE Healthcare, Piscataway, NJ) and a gel filtration
column (Superdex 200 10/300 GL) were used to remove exterior calcein. The elution buffer
contained 108 mM NaCl and 10 mM HEPES pH 7.4 (elution buffer). The equality of the
osmotic pressure in the interior and at the exterior of calcein-encapsulated ULVs was
confirmed using a Wescore 5500 vapor pressure osmometer (Logan, Utah). Dynamic light
scattering measurement using a Dynapro Nanostar (Wyatt Technology, Santa Barbra, CA)
indicated that the size exclusion chromatography (SEC) separated vesicles had an average
diameter of 120 nm.
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Snap-frozen polyQ35 aliquots collected at different time points were thawed on ice. In
addition to these aliquots, we also investigated the effect of pelleted aggregates. This was
done by centrifuging 100 μL peptide solution incubated for 7 days at 13000 rpm for 10 min.
Peptide pellet was washed by SEC elution buffer for 3 times before bringing the final
volume to 100 μL. ULV sample was prepared by mixing 100 μL peptide solution (100 μM)
with 880 μl SEC elution buffer; 20 μl calcein-encapsulated ULVs was added at last (final
peptide concentration was 10 μM). The mixture was immediately transferred into a 1 mL
quartz cuvette. Time-course fluorescence spectrum (23°C) was obtained using a Jasco
FP-8300 fluorometer (Easton, MD). The excitation and emission wavelengths were 494 and
515 nm, respectively, with a bandwidth of 2.5 nm for each wavelength. Fluorescence signal
I was collected every 20 s until the intensity reached a plateau. To obtain the maximum
intensity Imax when all calcein molecules become unenclosed, an aliquot of Triton X-100
was added to the peptide treated ULV sample. The percentage of calcein leakage is defined
as: F = (I - I0)/(Imax - I0) × 100%, where I0 is the fluorescence intensity from calceinencapsulated ULVs without peptide treatment.
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Solution AFM
A liquid-compatible Multimode 8 AFM (Bruker, Santa Barbara, CA) operated at the
PeakForce quantitative nanomechanics (QNM) mode was used for solution AFM study
(23°C). Fresh peptide aliquot (incubated for different days at 4°C) was diluted to 10 μM (10
mM HEPES at pH 7.4) and loaded into the AFM liquid cell, which contained a freshly
cleaved mica substrate. After equilibration (~10 min), peptide aggregates were scanned (in
solution) using a special silicon nitride tip that works with the PeakForce QNM mode
(model: Scanasyst-Fluid+). Square images were acquired at a scan rate of 0.6 Hz.
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We also study the effect of polyQ35 aggregates on mica supported lipid bilayers.
Experimental procedure for lipid bilayer preparation has been described before [33, 34].
Briefly, lipid small unilamellar vesicles (SUVs) in 10 mM HEPES pH 7.4 were generated by
ultrasonication using a Sonic Dismembrator. A mica supported lipid bilayer was formed by
injecting SUVs into the AFM liquid cell. After bilayer formation (~30 min, examined by
preliminary AFM scans), polyQ35 aggregates (20 μM) were injected into the liquid cell
using a syringe pump (50 μL/min). In situ AFM scans using PeakForce QNM mode were
performed with a peak force of ~300 pN. During each scan, the probe oscillates at 1 kHz
while it scans across the bilayer surface. On fly analysis of the oscillating force curves at
each position yields a map of mechanical property (i.e., the reduced Young’s modulus E*)
and another map of the adhesion force Fadh between the bilayer and the AFM tip (Fig. S1,
SI). Both maps have the same spatial resolution as the height image. All maps (e.g., height,
reduced Young’s modulus, and adhesion force) with the same resolution were collected in a
single scan.
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Results
Oligomer and fibril morphologies of polyQ35 revealed by solution AFM
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Amyloidogenic peptides can undergo different aggregation pathways, yielding polymorphic
oligomers, prefibrils, and fibrils [35]. Monomeric disaggregation using organic solvents is
typically used to study aggregation kinetics of polyQ peptides [36]. Here we are only
interested in different forms of polyQ35 aggregates interacting with lipid bilayers; therefore,
we prepare polyQ35 aggregates by directly dissolving lyophilized powder in HEPES buffer
(pH 7.4) without the intervening disaggregation process. To slow down polyQ aggregation,
we keep peptide stock solution at 4°C when not in use. By taking aliquots incubated for
different days at 4°C, we are able to obtain different proportions of polyQ35 aggregates (i.e.,
oligomers and fibrils).
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High-resolution structures of polyQ35 aggregates are obtained by solution AFM (Fig. 1).
Height profiles indicate that oligomers have a height of ~2 nm and an apparent width of ~10
nm. We use a spherical model to correct oligomer width influenced by the finite size of the
AFM tip (nominal radius of 2 nm): Woligomer=W2/8rtip, where W is the apparent width. The
corrected oligomer width is 6.2 nm, which gives rise to an oligomer volume,
2π(Woligomer/2)2h/3, of 40 nm3. To estimate the number of monomers per oligomer, we
need to know monomer volume. Assuming a density range of 1.2 to 1.5 g/ml for polyQ35
[37], the resulting monomer volume is 3.8 to 3.0 nm3. This gives rise to an estimation of ~10
to 13 monomers per oligomer. We note that in addition to peptide density, AFM tip size also
contributes greatly to the uncertainty of the estimated number of monomers per oligomer.
Fibrils are observed to coexist with oligomers (Fig. 1). Height profiles in two directions
indicate that fibrils have a height of ~4 nm, about twice of the oligomer height. Moreover,
twisted morphology is revealed by periodic height distribution along the fibril axis
(periodicity of ~13 nm). These observations suggest that polyQ35 fibrils might be formed by
intertwining two oligomer strings.
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At 4°C, polyQ35 undergoes slow aggregation, yielding different proportions of monomers,
oligomers, and fibrils. Figure 2 shows four aliquots incubated for different days at 4°C. We
note that polyQ are known to aggregate at room temperature when equilibrating in the AFM
liquid cell; more aggregates (oligomers and fibrils) are observed with longer incubation at
room temperature. The images in Fig. 2 are obtained with similar incubation time after
injection into the liquid cell. It is clear that the amount of aggregates increases with the
incubation days at 4°C. Amorphous aggregates are observed when there are abundant fibrils
(Fig. 2C and 2D). Globular oligomers with similar sizes are observed in all images. Height
probabilities indicate that the fibril height is independent on incubation time (Fig. 2E–2H).
Note that fibril peaks are located at ~3 nm, a value smaller than the fibril height estimated
from Fig. 1. This is due to the cylindrical shape of fibrils (only fibril apex has the maximum
height of ~4 nm).
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Secondary structure of polyQ35 aggregates revealed by FTIR
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To evaluate the secondary structure of polyQ35 aggregates after incubating for different
days, we use attenuated total reflection FTIR in solution. Similar to the AFM experiment, it
is expected (and experimentally confirmed) that polyQ35 undergoes aggregation when
equilibrating in the FTIR liquid cell. For this reason, we only compare the first scan after
transferring a fresh aliquot from the stock solution at 4°C. The absorption spectra for
aliquots incubated from 0 to 7 days are shown in Fig. 3. We also pelleted aggregates for an
aliquot incubated for 7 days (see Materials and Methods). The absorption spectrum for the
pellet is also displayed. Two major bands located at 1655 and 1607 cm−1 corresponding to
loop/turn and intermolecular β-sheet structures, respectively, are highlighted by dashed lines
[38, 39]. It is clear that the loop/turn band is progressively weakened while the β-sheet band
is enhanced (the largest change takes place during the first day of incubation). The observed
transition is consistent with our AFM data, which show that the amount of β-sheet enriched
aggregates increases with incubation days. Interestingly, the pelleted aggregates also display
a small loop/turn band. This can be explained by considering that polyQ aggregates contain
a small fraction of loop/turn motif.
GUV disruption revealed by fluorescence microscopy
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We use fluorescence microscopy of DOPC GUVs (diameter of ~30 μm) to qualitatively
study membrane perturbation endowed by polyQ35 aggregates. For the intact GUV,
fluorescent lipid rhodamine-DPPE is uniformly distributed over the vesicle (Fig. 4).
Addition of an equal volume of polyQ35 solution (incubated for 5 days at 4°C) results in
lipid bilayer disruption. This is clearly illustrated by the five vesicles with deflated shapes.
We note that addition of the same volume of HEPES buffer does not induce any vesicle
deformation. Moreover, the observed perturbation does not take place immediately
following the introduction of polyQ35; the majority of vesicle breakage occurs in ~10 min
after mixing.
Vesicle disruption revealed by calcein leakage
Our GUV experiment clearly shows that polyQ35 can induce lipid bilayer disruption. To
assess the kinetic impact of polyQ35 on membrane integrity, we use fluorescence
spectroscopy. Calcein-encapsulated ULVs (diameter of ~120 nm) are prepared by the
Biochim Biophys Acta. Author manuscript; available in PMC 2017 April 01.
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extrusion method, followed by SEC separation. Fluorescence intensity from intact vesicles is
small due to calcein self-quenching. When vesicles become leaky to calcein, the
fluorescence intensity increases; the increased amount is correlated with calcein leakage or
the degree of membrane disruption. We monitor calcein fluorescence for vesicles mixed
with polyQ35 incubated for 0, 1, and 6 days at 4°C, as well the pelleted aggregates from a 7day aliquot. The final peptide concentration in mixture is 10 μM. The same SEC portion of
calcein-encapsulated ULVs is used to eliminate lipid concentration variation. For the 0-day
aliquot, the degree of calcein leakage increases rapidly during the first few hours of mixing
(Fig. 5). The degree of calcein leakage levels off near ~8 h. Interestingly, only a fraction of
calcein molecules are released from vesicle interior even when the maximum leakage is
reached (i.e., maximum leakage < 100%). This indicates that even at maximum leakage, the
impaired lipid membrane is not completely damaged, i.e., a membrane barrier still exists to
prevent enclosed calcein from diffusing away. For aliquots incubated with 1 day and 6 days,
the maximum calcein leakage becomes less compared to the 0-day aliquot. Interestingly,
calcein leakage is also observed for the pelleted aggregates, albeit with longer equilibration
time required to reach leakage saturation.
Disruption of mica supported lipid bilayers revealed by solution AFM
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Both GUV and calcein leakage data indicate that polyQ35 confer a time-dependent
disruptive effect on lipid bilayers. To obtain detailed structural and mechanical impact of
polyQ35 on lipid bilayers, we use solution AFM. Mica supported planar DOPC bilayers are
prepared in the AFM liquid cell. To test whether polyQ35 monomers play a role in
modulating lipid bilayer structure, we first expose the DOPC bilayer to monomeric
supernatant, which was obtained by ultracentrifuging 20 μM polyQ35 powder dissolved in
10 mM HEPES pH 7.4 (maximum RCF of 266,000×g for 5 h). After incubating for 2 h in
the liquid cell, very little change of the DOPC bilayer was observed (data not shown). This
leads us to conclude that polyQ35 monomers do not disrupt bilayers, a result consistent with
previous findings [13, 19]. We next expose DOPC bilayers to aliquots of 20 μM polyQ35
incubated for different days at 4°C. Time-dependent bilayer remodeling is observed. This is
illustrated in Fig. 6 for the 0-day aliquot. Since monomers are not responsible for bilayer
disruption, the observed bilayer restructuring must be due to aggregated forms of polyQ35
(i.e., oligomers and fibrils).
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In addition to height images, high-resolution maps of the reduced Young’s modulus E* and
the adhesion force Fadh are also shown in Fig. 6 (see Supplementary Material for the
derivation of E* and Fadh from PeakForce QNM mode scanning). Using the thin shell theory
for lipid bilayers, the reduced Young’s modulus is proportionally associated with bilayer
lateral compressibility modulus KA and bilayer bending modulus KC: KA = H × E* / (1 - v2)
and KC = H3 × E* /24 (1 - v2, where H is the bilayer thickness and v is the Poisson ratio. It is
clear that both KA and KC are proportional to E*; a larger E* reflects a larger rigidity of the
bilayer. The adhesion force Fadh from AFM retracting force-distance curves characterizes
the strength of interactions between the bilayer surface and the AFM tip. Typically,
molecules such as lipids that have a tendency of being pulled out by the AFM tip exhibit
larger Fadh than those that are rigid such as amyloid fibrils.
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The time-dependent height images in Fig. 6 show that after exposing to polyQ35 aggregates,
the DOPC bilayer is gradually modified. Regions corresponding to the intact bilayer (e.g.,
region a) are first converted into partially disrupted organization (e.g., region b), which is
then further disrupted to form the fully disrupted bilayer (e.g., region c). During the
disruption process, fibrils are observed to deposit on bilayer surfaces, mainly in partially and
fully disrupted regions. This indicates that the interactions between fibrils and lipid bilayers
may not be strong enough for fibril deposition. Exposure of buried lipid motifs facilitates the
sorting of fibrils onto the bilayer surface. Height probabilities of the three height images
(Fig. 6J) reveal that the disrupted bilayer has a smaller height than the intact bilayer. This is
further illustrated by height profiles crossing the bilayer surface (Fig. 7). For intact bilayer,
the height variation is small (rmsd ≈ 0.06 nm). Similar height variation is observed for the
unperturbed region a; partial (region b) and full (region c) disruption results in ~0.2 and ~0.6
nm height decrease, respectively. Notice that both the partially and fully disrupted regions
exhibit larger roughness compared to the intact bilayer.
Examination of Fig. 6C indicates that there are numerous small patches on the bilayer
surface. AFM scans with larger magnification reveal that these small patches can have
circular or irregular shapes depending on the degree of bilayer disruption and the incubation
days of polyQ35 at 4°C (Fig. 8). After extracting the three species present in Fig. 8 (i.e.,
fibrils, circularly or irregularly shaped patches, and the fully disrupted region) using
appropriate height thresholds, we find that the patches have an average height larger than
that of the fully disrupted region by ~0.6 nm (Fig. 8G and 8H). Compared to the height
profiles in Fig. 7, the height difference of ~0.6 nm suggests that these patches correspond to
intact bilayer regions, rather than polyQ35 oligomers. This statement is further supported by
our analysis of bilayer material and adhesion force properties as discussed below.
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In addition to height contrasts between the intact, the partially and the fully disrupted
bilayers in Fig. 6, the simultaneously obtained reduced Young’s modulus maps indicate that
the fully disrupted region has the largest rigidity, followed by the partially disrupted and the
intact regions (Fig. 6D). We note that (i) the obtained rigidity is a collective mechanical
property incorporating lipids and peptide aggregates in each pixel, and (ii) the absolute
values of E* are dependent on scanning parameters and the AFM tip. Nevertheless, the
relative rigidities between different regions on the bilayer surface are accurately reflected by
the reduced Young’s modulus map. The observed rigidity contrasts between the three
regions in Fig. 6D can be understood by considering that regions with larger amount of
polyQ35 aggregates, which causes bilayer disruption, have larger rigidity than that of fluid
phase lipids. Similar to the rigidity map, the adhesion force map shows that there are distinct
contrasts between the three types of bilayer regions (Fig. 6G). While it is expected that the
intact region has the largest adhesion force, the smaller adhesion force for the partially
disrupted region than that of the fully disrupted region is quite surprising (Fig. 6G). This
observation can be reconciled by considering that the fully disrupted region exposes
adhesive lipid motifs such as the interfacial hydrocarbon chains, which are still buried in the
partially disrupted region. Consequently, the adhesion force experienced by the AFM tip can
be larger in the fully disrupted region than in the partially disrupted region – assuming that
hydrocarbon chains are more adhesive than polar headgroups. Histograms of the reduced
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Young’s modulus and the adhesion force maps (Fig. 6J) are consistent with our qualitative
assessment that larger bilayer disruption results in larger bilayer rigidity and smaller bilayer
adhesion force.
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Figure 6 shows the overall contrast between the three types of regions depending on the
degree of bilayer disruption. Scans with larger magnifications reveal more details of bilayer
mechanical and adhesion force properties (Fig. S2, Supplementary Material). Compared to
the fully disrupted region, the circularly or irregularly shaped patches exhibit smaller rigidity
and larger adhesion force (Fig. S2). These properties are consistent with our earlier assertion
that the protruded patches (by ~0.6 nm) correspond to intact bilayer regions, rather than
polyQ35 oligomers. In addition to the intact patches, fibrils are also observed in the largemagnification images. In particular, we find that compared to the fully disrupted region,
fibrils have a smaller adhesion force (Fig. S2). Moreover, the rigidity of fibrils is
comparable to that of the fully disrupted bilayer. This observation supports the notion that
the disrupted region is enriched with polyQ35 aggregates.
DOPC bilayers exposed to polyQ35 aliquots incubated for 1 day and 9 days are shown in
Fig. S3 (Supplementary Material). Similar to the 0-day aliquot, fibrils deposited on bilayer
surfaces are observed in all images. Importantly, all aliquots are able to induce bilayer
disruption. This is confirmed by comparing height variances between the intact and
disrupted bilayers using a two-sample F-test (after excluding regions with deposited fibrils).
The resulting p values are < 0.01 for all of the disrupted bilayers in Fig. S3. One difference
is the intact lipid patches induced by the 0-day and 1-day aliquots, while no patches are
observed for the 9-day aliquot. The difference could be due to different equilibration time in
the AFM liquid cell.
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One interesting question is whether lipid bilayer surface can promote or inhibit polyQ
aggregate formation. Figure 9 shows two consecutive scans (30 min apart) for a DOPC
bilayer exposed to 20 μM polyQ35 incubated for 0 day at 4°C. It is clear that the later scan
contains more fibrils. Close examination indicates that some of the fibrils in the earlier scan
(Fig. 9A) become longer in the later scan (Fig. 9B). To quantify fibril elongation, we
calculate the aspect ratio of each fibril. This is done by digitally tracing fibril contours (Fig.
S4, Supplementary Material). The length of each fibril is estimated based on the fibril area
and the assumption that each fibril has the same width (e.g., 12 nm). Once the length is
determined, the aspect ratio is the ratio of the fibril length over the constant fibril width.
Note that a different estimation of the fibril width only shifts the aspect ratio histograms
(Fig. 9D and 9E) to the left or right. Consistent with our preliminary assessment of fibril
elongation, there are more fibrils with larger aspect ratios in the later scan. It seems that after
deposition onto the bilayer surface, fibrils can continuously grow in length by recruiting
oligomers to the vicinity of the bilayer surface.
Height profiles along two directions of a fibril in Fig. 9A indicates that the bilayer
associated fibril has a height of ~2 nm and an apparent width of ~12 nm (Fig. 9C). Height
probability distributions within rectangular regions containing all the fibrils support that the
fibrils have an average height of ~2 nm larger than that of the bilayer surface (Fig. 9F and
9G). (The rectangular regions used for histogram calculation are shown in Fig. S5,
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Supplementary Material.) This value is smaller than the fibril height when adsorbed on mica
surface (Figs. 1 and 2). The difference can be explained by considering that the bottom of
the cylindrical fibrils protrudes slightly into the headgroup region of the bilayer. As a result,
the relative height between the bilayer surface and the apex of the fibril is smaller than the
actual height of the fibril. Fibril indentation could contribute to bilayer disruption, although
this effect is minimal compared to the extensive disruption where fibrils are not present
(fully disrupted region in Figs. 6 and 8).

Discussion
Globular oligomers of polyQ

Author Manuscript

Identifying different forms of polyQ aggregates is relevant to the development of therapeutic
strategies targeting specific toxic species in expanded CAG repeat diseases [40-42]. Earlier
kinetic studies on synthetic polyQ peptides suggested that the nucleated growth of fibrillar
aggregates involves a critical nucleus size of one monomer [4]. Fibrils are spontaneously
formed by the metastable monomeric nucleus. Other studies challenged this view by
showing that soluble aggregates do form during the monomer-fibril conversion [43]. The
apparent discrepancy was later reconciled (to some degree) by a systematic study showing
that nucleus size is repeat length dependent [5]. Short stretches aggregate via nuclei up to 4
monomers, while longer stretches undergo monomeric nucleation. Other studies indicated
that flanking sequences could also modify nucleus size [6, 44, 45].

Author Manuscript

One source of confusion is the difficulty of visually detecting the various fibrillar precursors
with polymorphic and possibly transient nature. In this regard, high-resolution AFM is
invaluable for revealing different amyloid aggregates present on or off aggregation pathways
of polyQ [40]. Indeed, oligomers of polyQ without or with the htt N-terminal have been
observed using AFM [7, 46]. Although the reported dimensions vary, AFM studies support
that multi-monomeric oligomers of long polyQ stretches do form [47]. This, however, does
not exclude the possibility of monomeric nucleation pathway, since the preparation protocol
[48, 49] and the mica surface [50] can alter polyQ aggregation behavior, as well as the
peptide sequence used in each study [5, 6]. We note that our polyQ35 stock solution was
incubated at 4°C and examined at room temperature. It has been reported that htt-polyQ
complex contains more loop/turn structures when incubated at 4°C than at 37°C [39]. This
observation has little effect on our data since we clearly see the intermolecular β-sheet band
in all of the aliquots examined (Fig. 3), while this band is diminished in the reported study at
4°C. One possibility is that all our measurements are performed at room temperature, which
could bring the aliquots to “normal temperature” behavior.
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Lipid bilayer perturbation
Cell membranes have been proposed as the primary target by an array of amyloidogenic
proteins and peptides [13, 19, 27]. To explore membrane perturbation induced by polyQ35
aggregates, we use a number of experimental approaches. We find that polyQ35 aggregates
can perturb lipid bilayer integrity, yielding deflated GUVs. Our fluorescence spectroscopy
data indicate that after exposing to polyQ35 aggregates, lipid bilayers become permeable to
calcein. Moreover, the efficacy of calcein leakage is inversely related to the incubation time
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of polyQ35 at 4°C. The disruptive effect of polyQ35 aggregates on lipid bilayers is further
revealed by high-resolution solution AFM measurements. Interestingly, we find that lipid
bilayer disruption is a two-step process. Lipid motifs such as phosphate group residing
closer to the water-bilayer interface are first exposed, resulting in partially disrupted
morphology; full disruption is achieved by exposing deeper lipid motifs such as the
glycerol-carbonyl group. The observed two-step process highlights that peptide
concentration and equilibration time can be important parameters in explaining discrepant
membrane toxicities of amyloid aggregates. Similar lipid bilayer disruption/remodeling has
been observed for a broad spectrum of amyloid aggregates [51-53]. Studies on interactions
between polyQ and lipid bilayers have also been performed [25]. The authors found that
polyQ monomers do not appreciably aggregate and disrupt lipid bilayers; addition of a
flanking sequence significantly augments bilayer disruption. Since our data clearly show
that simple polyQ stretches is fully capable of disrupting lipid bilayers, the discrepancy can
be attributed to the incubation time that is required to generate toxic polyQ aggregates. We
overcome the problem by skipping monomeric disaggregation process.
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In addition to topographical information, our AFM measurements also reveal bilayer
mechanical and adhesion force properties. We find that bilayer rigidity increases
continuously when the bilayer undergoes partial and full disruption by polyQ35 aggregates.
Interestingly, the adhesion force between the bilayer and the AFM tip first decreases and
then increases during the two-step disruption process. Since proper membrane function
requires balanced structural and mechanical properties, our AFM data provide additional
perspective on how polyQ aggregates might hamper cellular activity. Our observation of the
enhanced bilayer rigidity by polyQ adsorption and insertion is consistent with previous
AFM force measurements, which showed that larger puncture forces are required for
bilayers exposed to amyloid-β prefibrillar oligomers [21, 54]. Using an AFM mode referred
to as the scanning probe acceleration microscopy (SPAM), Legleiter and coworkers
measured the maximum tapping force (Fmax) and minimal tapping force (Fmin) of lipid
bilayers during each tapping event [24, 25, 49, 55]. The authors found that addition of
amyloid aggregates decreases Fmax and Fmin. By correlating Fmax to bilayer rigidity and
Fmin to bilayer-tip adhesion force, the authors concluded that amyloid aggregates
simultaneously decrease bilayer rigidity and adhesion force. While the later conclusion is in
accordance with ours – although we obtain a two-step process, which was not seen in their
studies – their result of smaller bilayer rigidity contradicts our data. One explanation is that
unlike the reduced Young’s modulus, which is obtained by fitting force-distance curves,
Fmax from SPAM only measures one force during a tapping cycle. An alternative
explanation is that the studies by Legleiter and coworkers used a different lipid bilayer, as
well as the addition of a flanking sequence to polyQ stretches.
It is clear that polyQ aggregates can modulate structural and mechanical properties of lipid
bilayers. The vexing question is what aggregate is responsible for the observed change. Our
solution AFM measurements on mica indicate that globular oligomers and short fibrils are
the dominant aggregated forms of polyQ35. Exposing lipid bilayers to polyQ35 causes
bilayer disruption in an equilibration time dependent manner. The final bilayer is composed
of intact lipid patches, fully disrupted region, and polyQ fibrils (Fig. 8). Where do the
oligomers go? The answer is hinted by the fully disrupted region without fibrils. Since
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monomers do not cause bilayer disruption [13, 19], the only candidate for the observed
change in the fully disrupted region is oligomers, i.e., polyQ35 oligomers are the toxic
aggregates causing bilayer disruption. This conclusion is supported by several lines of
evidence: (i) oligomers can increase the rigidity of the fully disrupted region (Fig. 6), and
(ii) bilayer thickness (~3-4 nm) is compatible with oligomers but not fibrils (Fig. 1).
Although controversies remain pertaining to cytotoxicity of different forms of amyloid
aggregates [56], the implication from our data that globular oligomers cause membrane
disruption agrees with many studies showing that formation of inert fibrils is a coping
response to toxic oligomers [57].
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Several compelling mechanisms have been suggested to explain membrane permeabilization
induced by amyloidogenic proteins and peptides: (i) nonspecific membrane disruption [19,
58], (ii) transmembrane pore formation [26], and (iii) detergent-like micellization [59].
Although the exact mechanism is most likely protein and aggregate dependent, our
experimental data support nonspecific membrane disruption by polyQ aggregates. The
absence of detergent-like effect is evident based on the calcein leakage data, which indicates
that even when the leakage reaches maximum, there are still significant amount of calcein
molecules enclosed by lipid vesicles. This will not be the case if lipids are extracted to form
micelle-like structures with polyQ aggregates. The absence of annular pores is confirmed by
our high-resolution solution AFM measurements (Fig. S3, Supplementary Material). Aside
from occasional defects, the majority of the fully disrupted bilayer is homogeneous. We note
that our solution AFM has enough resolution to see transmembrane protein oligomers of ~5
nm diameter in lipid bilayers (unpublished data). The mechanism of generic membrane
disruption by polyQ aggregates is consistent with several lines of experimental data [19, 58,
60, 61].
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Conclusions
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In this study, we prepared aggregates of a polyQ stretch containing 35 glutamine residues at
4°C. Depending on the incubation time, globular oligomers and short fibrils are observed
using solution AFM on a mica surface. Size and volume estimation reveals that polyQ35
oligomers contain ~10-13 monomers, although the estimation is complicated by
uncertainties due to oligomer size heterogeneity and the finite size of AFM tips. PolyQ35
fibrils have a twisted morphology and are most likely formed by intertwining two oligomer
strings. Using attenuated total refection FTIR, we show that polyQ35 aggregates are
enriched in intermolecular β-sheet structure; the content of β-sheet increases with incubation
time. We also study the impact of polyQ35 aggregates on vesicular and mica supported
planar lipid membranes. Vesicle breakage is observed using fluorescence microscopy of ~30
μm sized GUVs. Similarly, time-dependent fluorescence spectroscopy measurement reveals
that lipid vesicles become permeable to calcein after introducing polyQ35 aggregates.
Interestingly, we observe that even at the maximum leakage, significant amount of calcein
molecules are still encapsulated by lipid vesicles. This suggests that polyQ35 aggregates
only modulate lipid membrane integrity, but do not cause membrane fragmentation. Detailed
structural and mechanical perturbation of lipid membranes is obtained by solution AFM. We
find that membrane disruption proceeds by partially decreasing bilayer height by ~0.2 nm,
followed by a more aggressive decrease of ~0.4 nm (total of ~0.6 nm). In addition to the
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height contrast, the resulting partially and fully disrupted bilayers have distinct rigidity and
adhesion force properties compared to the intact bilayer. Specifically, the bilayer rigidity
increases as the intact bilayer becomes partially and fully disrupted. Surprisingly, the
adhesion force first decreases and then increases during the disruption process. Finally, we
show that membrane associated fibrils can grow in length, although the role of lipid bilayer
surface on polyQ aggregation (e.g., promotion or suppression of fibril growth compared to
the aqueous solution) is unclear based on our study [56, 62].

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
•

PolyQ forms oligomers and fibrils

•

PolyQ aggregates permeabilize lipid bilayers

•

PolyQ aggregates disrupts lipid bilayer organization by a two-step process

•

PolyQ aggregates modulate lipid bilayer mechanical and adhesion force
properties

Author Manuscript
Author Manuscript
Author Manuscript
Biochim Biophys Acta. Author manuscript; available in PMC 2017 April 01.

Ho et al.

Page 19

Author Manuscript
Figure 1.
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PolyQ35 aggregates on mica surface obtained by solution AFM. (A) Height image. Scale
bar = 50 nm. (B) Height profiles along the six trajectories indicated in (A). (Only the central
portion containing aggregates is shown.) Globular oligomers have a height of ~2 nm and a
width of ~10 nm; fibrils have a height of ~4 nm and a width of ~12 nm. Twisted
morphology is seen for the fibril with a periodicity of ~13 nm along the fibril axis.
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Solution AFM height images of polyQ35 aggregates incubated for 0 day (A), 1 day (B), 2
days (C), and 9 days (D) at 4°C. Insets show representative fibrils and oligomers with 3-time
magnification. Images are obtained after similar equilibration times in the AFM liquid cell at
23°C. Scale bars = 100 nm. (E–H) Height probabilities for the corresponding height images
in (A–D).
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Figure 3.

Attenuated total reflection FTIR absorption spectra of polyQ35 incubated for different days
at 4°C (indicated by the values next to each spectrum). The spectrum of the pelleted
aggregates is obtained by centrifuging an aliquot incubated for 7 days.
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Figure 4.

Fluorescence microscopy of DOPC GUVs before and after mixing with polyQ35 aliquot.
The peptide has been incubated for 5 days at 4°C, and the final peptide concentration is 15
μM. Scale bars = 10 μm. The left panel shows an intact GUV. After mixing with polyQ35,
GUVs become deflated (five representative vesicles on the right).
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Figure 5.

Calcein leakage of DOPC ULVs induced by polyQ35 incubated for different days at 4°C, as
well as the pelleted aggregates from a 7-day aliquot. The excitation and emission
wavelengths are 494 and 515 nm, respectively. Calcein-encapsulated ULVs are prepared
using SEC separation. Snap-frozen peptide aliquots are mixed with the same portion of
ULVs to eliminate lipid concentration variation. The final peptide concentration is 10 μM.
Time-course measurements are performed at 23°C. Fluorescence curve for ULV solution
without polyQ35 is also shown.
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Figure 6.

Solution AFM images of mica supported DOPC bilayers exposed to 20 μM polyQ35
aggregates incubated for 0 day at 4°C. (A–C) Height images, (D–F) reduced Young’s
modulus E* maps, and (G–I) adhesion force maps. Scale bars = 200 nm. The three rows
correspond to three time points (~20 min apart) when the measurements are performed.
Three regions are indicated as a, b, and c in (A), (D), and (G) to highlight the intact bilayer,
the partially disrupted bilayer, and the fully disrupted bilayer, respectively. (J) Histograms
(normalized) of the corresponding height, reduced Young’s modulus, and adhesion force
maps at the three time points shown in (A–I).
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Figure 7.

Solution AFM height images of a DOPC bilayer modulated by polyQ35 aggregates. (A)
DOPC bilayer, and (B) DOPC bilayer e posed to 20μM polyQ35 aggregates incubated for 0
day at 4°C. Scale bars = 200 nm. (C) and (D) are height profiles (in nm) along the solid
green lines in (A) and (B), respectively. Three regions in (D) are indicated. Region a
corresponds to intact bilayer; region b corresponds to partially disrupted bilayer; region c
corresponds to fully disrupted bilayer. Compared to the intact bilayer, the height of the
partially and fully disrupted bilayers is smaller by ~0.2 and ~0.6 nm, respectively.
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Solution AFM height images of DOPC bilayers exposed to 20 μM polyQ35 incubated for 0
day (A) and 1 day (B). Intact lipid patches (C and D) and polyQ35 fibrils (E and F) are
digitally extracted by setting appropriate height thresholds. (G) and (H) are normalized
height probabilities for the three species: a, fibrils; b, intact lipid patches; and c, disrupted
lipid regions. The average height difference between the disrupted and the intact lipid
regions is ~0.6 nm. Scale bars = 100 nm.
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Figure 9.

PolyQ35 fibril elongation on DOPC bilayer surface. Scale bars = 200 nm. Five ellipses (a–e)
are shown to highlight where fibril elongation occurs. (C) Height profiles along two
trajectories depicted in (A). (D) and (E) are aspect ratio histograms of polyQ35 fibrils in (A)
and (B), respectively. (F) and (G) are height probabilities in rectangular regions containing
all fibrils (Fig. S4, Supplementary Material). The average height difference between fibrils
and the bilayer surface is ~2 nm.
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